Saccade abnormalities in autopsy-confirmed frontotemporal lobar degeneration and alzheimer disease

Archives of Neurology

Volumn 69, Issue 4, 2012, Pages 509-517

  Boxer, Adam L ^a   Garbutt, Siobhan ^a,b   Seeley, William W ^a   Jafari, Aria ^a   Heuer, Hilary W ^a,b   Mirsky, Jacob ^a   Hellmuth, Joanna ^a   Trojanowski, John Q ^c   Huang, Erik ^b   DeArmond, Steven ^b   Neuhaus, John ^a   Miller, Bruce L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ANATOMICAL VARIATION; ARTICLE; AUTOPSY; BRAIN SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; EYE MOVEMENT DISORDER; EYE TRACKING; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; NEUROANATOMY; NEUROPATHOLOGY; OCULOMOTOR SYSTEM; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN DNA BINDING; SACCADIC EYE MOVEMENT; VELOCITY; VISUAL SYSTEM PARAMETERS; VOXEL BASED MORPHOMETRY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AUTOPSY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; FEMALE; FRONTOTEMPORAL LOBAR DEGENERATION; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; OCULAR MOTILITY DISORDERS; PSYCHIATRIC STATUS RATING SCALES; ROC CURVE; SACCADES;

EID: 84859987906     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.1021     Document Type: Article

References (43)

1. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-1554.
2. Lomen-Hoerth C, Anderson T, Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology. 2002;59(7):1077-1079.
3. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain. 2005;128(pt 6):1247-1258. (Pubitemid 40826179)
4. Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003; 54(suppl 5):S15-S19. (Pubitemid 36760148)
5. Kertesz A. Pick Complex: an integrative approach to frontotemporal dementia: primary progressive aphasia, corticobasal degeneration, and progressive supranuclear palsy. Neurologist. 2003;9(6):311-317. (Pubitemid 37484850)
6. Kertesz A, McMonagle P, Blair M, Davidson W, Munoz DG. The evolution and pathology of frontotemporal dementia. Brain. 2005;128(pt 9):1996-2005. (Pubitemid 41253267)
7. Hodges JR, Davies RR, Xuereb JH, et al. Clinicopathological correlates in frontotemporal dementia. Ann Neurol. 2004;56(3):399-406. (Pubitemid 39166559)
8. Josephs KA, Petersen RC, Knopman DS, et al. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology. 2006;66(1):41-48. (Pubitemid 43739589)
9. Cairns NJ, Bigio EH, Mackenzie IR, et al Consortium for Frontotemporal Lobar Degeneration. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114(1):5-22. (Pubitemid 47029055)
10. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol. 2009;117(1):15-18.
11. Urwin H, Josephs KA, Rohrer JD, et al; FReJA Consortium. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol. 2010;120(1):33-41.
12. Josephs KA. Frontotemporal dementia and related disorders: deciphering the enigma. Ann Neurol. 2008;64(1):4-14.
13. Boxer AL, Boeve BF. Frontotemporal dementia treatment: current symptomatic therapies and implications of recent genetic, biochemical, and neuroimaging studies. Alzheimer Dis Assoc Disord. 2007;21(4):S79-S87. (Pubitemid 350307449)
14. Meyniel C, Rivaud-Péchoux S, Damier P, Gaymard B. Saccade impairments in patients with fronto-temporal dementia. J Neurol Neurosurg Psychiatry. 2005;76(11):1581-1584. (Pubitemid 41531711)
15. Boxer AL, Garbutt S, Rankin KP, et al. Medial versus lateral frontal lobe contributions to voluntary saccade control as revealed by the study of patients with frontal lobe degeneration. J Neurosci. 2006;26(23):6354-6363.
16. Garbutt S, Matlin A, Hellmuth J, et al. Oculomotor function in frontotemporal lobar degeneration, related disorders and Alzheimer's disease. Brain. 2008;131(pt 5):1268-1281.
17. Donker Kaat L, Boon AJ, Kamphorst W, Ravid R, Duivenvoorden HJ, van Swieten JC. Frontal presentation in progressive supranuclear palsy. Neurology. 2007;69(8):723-729. (Pubitemid 47300928)
18. Williams DR, Lees AJ. Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol. 2009;8(3):270-279.
19. Dickson DW, Ahmed Z, Algom AA, Tsuboi Y, Josephs KA. Neuropathology of variants of progressive supranuclear palsy. Curr Opin Neurol. 2010;23(4):394-400.
20. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119(1):1-4.
21. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging. 1997;18(4)(suppl):S1-S2.
22. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology. 1996;47(1):1-9. (Pubitemid 26243849)
23. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43(11):2412-2414. (Pubitemid 23346995)
24. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34(7):939-944. (Pubitemid 14076461)
25. Rohrer JD, Geser F, Zhou J, et al. TDP-43 subtypes are associated with distinct atrophy patterns in frontotemporal dementia. Neurology. 2010;75(24):2204-2211.
26. Rosen HJ, Gorno-Tempini ML, Goldman WP, et al. Patterns of brain atrophy in frontotemporal dementia and semantic dementia. Neurology. 2002;58(2):198-208. (Pubitemid 34084208)
27. Morris HR, Gibb G, Katzenschlager R, et al. Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy. Brain. 2002;125(pt 5):969-975. (Pubitemid 34464609)
28. Viskontas IV, Boxer AL, Fesenko J, et al. Visual search patterns in semantic dementia show paradoxical facilitation of binding processes. Neuropsychologia. 2011;49(3):468-478.
29. Rottach KG, Riley DE, DiScenna AO, Zivotofsky AZ, Leigh RJ. Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol. 1996;39(3):368-377. (Pubitemid 26100761)
30. Vidailhet M, Rivaud S, Gouider-Khouja N, et al. Eye movements in parkinsonian syndromes. Ann Neurol. 1994;35(4):420-426.
31. Rivaud-Péchoux S, Vidailhet M, Gallouedec G, Litvan I, Gaymard B, Pierrot- Deseilligny C. Longitudinal ocular motor study in corticobasal degeneration and progressive supranuclear palsy. Neurology. 2000;54(5):1029- 1032.
32. Murray R, Neumann M, Forman MS, et al. Cognitive and motor assessment in autopsy-proven corticobasal degeneration. Neurology . 2007;68(16):1274-1283. (Pubitemid 46625973)
33. Alladi S, Xuereb J, Bak T, et al. Focal cortical presentations of Alzheimer's disease. Brain. 2007;130(pt 10):2636-2645. (Pubitemid 47511719)
34. Averbuch-Heller L, Helmchen C, Horn AK, Leigh RJ, Büttner-Ennerver JA. Slow vertical saccades in motor neuron disease: correlation of structure and function. Ann Neurol. 1998;44(4):641-648. (Pubitemid 28477852)
35. Gizzi M, DiRocco A, Sivak M, Cohen B. Ocular motor function in motor neuron disease. Neurology. 1992;42(5):1037-1046.
36. Moon SY, Lee BH, Seo SW, Kang SJ, Na DL. Slow vertical saccades in the frontotemporal dementia with motor neuron disease. J Neurol. 2008;255(9):1337-1343.
37. Donaghy C, Pinnock R, Abrahams S, et al. Slow saccades in bulbar-onset motor neurone disease. J Neurol. 2010;257(7):1134-1140.
38. Hardwick A, Rucker JC, Cohen ML, et al. Evolution of oculomotor and clinical findings in autopsy-proven Richardson syndrome. Neurology. 2009;73(24):2122-2124.
39. Bhidayasiri R, Riley DE, Somers JT, Lerner AJ, Büttner-Ennever JA, Leigh RJ. Pathophysiology of slow vertical saccades in progressive supranuclear palsy. Neurology. 2001;57(11):2070-2077.
40. Trojanowski JQ, Wray SH. Vertical gaze ophthalmoplegia: selective paralysis of downgaze. Neurology. 1980;30(6):605-610. (Pubitemid 10073086)
41. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol. 1964;10:333-359.
42. Boxer AL, Rankin KP, Miller BL, et al. Cinguloparietal atrophy distinguishes Alzheimer disease from semantic dementia. Arch Neurol. 2003;60(7):949-956. (Pubitemid 36858354)
43. Litvan I, Campbell G, Mangone CA, et al. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olzewski syndrome) form related disorders? a clinicopathological study Brain. 1997;120(pt 1):65-74. (Pubitemid 27081261)